PV pharm branch, vendor, cage 0U9U0
Ended Awarded Last action
- Contract number
- SPE2D826F08U7
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $116,324
Award facts
- Contract value 100% obligated
- $116,324.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., received a delivery order valued at $116,324.40 from the Defense Logistics Agency's Medical Supply Chain on January 19, 2026, with an ultimate completion date of January 20, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award leverages Amerisourcebergen's existing Indefinite Delivery Contract with DLA Troop Support Medical, a $999.99 million comprehensive pharmaceutical supply vehicle running through December 2026 that enables the company to deliver a broad range of pharmaceutical products, medical supplies, vaccines, and specialized healthcare commodities to support military healthcare systems globally.
The Defense Logistics Agency, which manages medical supply chains for the Department of Defense and military healthcare programs, relies on prime vendors like Amerisourcebergen to ensure consistent delivery of critical pharmaceutical and medical products to military treatment facilities and veteran healthcare systems. Through its substantial IDC with DLA Troop Support Medical, Amerisourcebergen has demonstrated the capability to fulfill federal procurement requirements for essential medications and medical supplies across multiple therapeutic domains, including specialty drugs, vaccines, and medical devices. The DLA is currently planning to transition to Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple regional awards, positioning established vendors like Amerisourcebergen to continue serving defense healthcare operations.
Quick answers
Who was awarded contract SPE2D826F08U7?
SPE2D826F08U7 was awarded to Amerisourcebergen Drug Corp by Medical Supply Chain (Troop Support) on January 19, 2026.
How much is contract SPE2D826F08U7 worth?
The government has obligated $116,324 on SPE2D826F08U7.
Is contract SPE2D826F08U7 an order under another contract?
Yes. SPE2D826F08U7 is a delivery order under SPE2DX22D0069, an indefinite delivery contract.
Was contract SPE2D826F08U7 competed?
The extent of competition for SPE2D826F08U7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award